These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Hydralazine antinuclear antibodies and the lupus syndrome. Ramsay LE; Silas J; Freestone S Br Med J (Clin Res Ed); 1982 Jun; 284(6330):1711. PubMed ID: 6805676 [No Abstract] [Full Text] [Related]
7. Hydralazine, antinuclear antibodies, and the lupus syndrome. Mansilla-Tinoco R; Harland SJ; Ryan PJ; Bernstein RM; Dollery CT; Hughes GR; Bulpitt CJ; Morgan A; Jones JM Br Med J (Clin Res Ed); 1982 Mar; 284(6320):936-9. PubMed ID: 6802356 [TBL] [Abstract][Full Text] [Related]
8. Prospective study of immune response to hydralazine and development of antideoxyribonucleoprotein in patients receiving hydralazine. Carpenter JR; McDuffie FC; Sheps SG; Spiekerman RE; Brumfield H; King R Am J Med; 1980 Sep; 69(3):395-400. PubMed ID: 6968159 [TBL] [Abstract][Full Text] [Related]
18. [Procainamide- and hydralazine-induced antinuclear antibodies in Japanese]. Nishikai M; Sugimoto M; Sato A; Honda M; Naito M; Nagoshi H Nihon Naika Gakkai Zasshi; 1987 May; 76(5):686-8. PubMed ID: 3509914 [No Abstract] [Full Text] [Related]
19. Acute immunologic hydralazine reaction. Clinical and serological changes after hydralazine administration to a patient with circulating antinuclear antibodies. Alarcón-Segovia D Rev Invest Clin; 1972; 24(2):167-74. PubMed ID: 4538312 [No Abstract] [Full Text] [Related]